Kieffer Tara Lynn
Insider CIK 1834835 · ENTA Sr. VP, New Product Dev.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2026-02-12 | 2026-02-13 | 1,575 | — | $0 | 32,195 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2026-02-12 | 2026-02-13 | 4,987 | — | $0 | 37,182 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2026-02-12 | 2026-02-13 | 3,257 | $14.25 | $46.4K | 33,925 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2025-12-05 | 2025-12-05 | 2,106 | $14.23 | $30.0K | 30,620 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2025-12-01 | 2025-12-03 | 753 | $14.12 | $10.6K | 32,726 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2025-11-25 | 2025-11-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2025-02-12 | 2025-02-14 | 3,326 | $5.59 | $18.6K | 33,479 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2025-02-12 | 2025-02-14 | 7,500 | — | $0 | 36,805 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2024-12-06 | 2024-12-10 | 2,283 | $8.06 | $18.4K | 29,305 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2024-12-01 | 2024-12-03 | 753 | $8.60 | $6.5K | 31,588 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2024-11-27 | 2024-11-27 | 81,000 | — | $0 | 81,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2024-06-17 | 2024-06-17 | 7,266 | $12.33 | $89.6K | 32,341 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2024-02-12 | 2024-02-14 | 3,320 | — | $0 | 40,580 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2024-02-12 | 2024-02-14 | 973 | $12.41 | $12.1K | 39,607 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2023-12-05 | 2023-12-06 | 2,125 | $9.63 | $20.5K | 37,260 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2023-12-01 | 2023-12-05 | 753 | $9.49 | $7.1K | 39,385 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2023-11-22 | 2023-11-22 | 83,000 | — | $0 | 83,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2023-02-13 | 2023-02-15 | 6,725 | $52.77 | $354.9K | 40,138 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2023-02-13 | 2023-02-15 | 11,747 | — | $0 | 46,863 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2023-02-13 | 2023-02-15 | 9,250 | — | $0 | 35,116 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2022-12-01 | 2022-12-05 | 498 | $44.33 | $22.1K | 25,866 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2022-11-23 | 2022-11-28 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2022-11-23 | 2022-11-28 | 18,500 | — | $0 | 26,364 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2022-02-14 | 2022-02-15 | 552 | $62.49 | $34.5K | 7,864 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2022-02-14 | 2022-02-15 | 1,289 | — | $0 | 8,416 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2022-02-14 | 2022-02-15 | 327 | — | $0 | 7,127 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2021-11-19 | 2021-11-23 | 28,400 | — | $0 | 28,400 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2021-11-19 | 2021-11-23 | 6,800 | — | $0 | 6,800 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2020-12-07 | 2020-12-08 | 65,000 | — | $0 | 65,000 | SEC↗ |